Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Acidity Level of Blood From Primary Molar's Pulp While Undergoing Pulpotomy or Pulpectomy Procedure

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Hadassah Medical Organization
Sponsor:
Information provided by (Responsible Party):
Moti Moskovitz, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01486537
First received: December 3, 2011
Last updated: June 12, 2013
Last verified: June 2013
  Purpose

The aim of this study is to evaluate the level of acidity of blood samples that are been taken from pulp chambers of primary molars undergoing pulpotomy or pulpectomy procedures. Our hypothesis is that samples from teeth undergoing pulpectomy would be acidic while samples from teeth undergoing pulpotomy would bo neutral.


Condition
Healthy

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Biospecimen Retention:   None Retained

blood specimens which are undergoing Astrop test (acidity level .po2 pco2)


Estimated Enrollment: 50
Study Start Date: December 2011
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
theeth undergoing pulpotomy
teeth undergoing pulpectomy

Detailed Description:

The samples will be collected by 1 m"l syringe that is pre-washed with Heparin.than the samples will be analyzed in an Astrop machine of neonates.

  Eligibility

Ages Eligible for Study:   3 Years to 13 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

healthy children undergoing dental treatment by residents in Hadassah hospital Jerusalem.

Ages between 3-13 years old.

Criteria

Inclusion Criteria:

  • no systemic disease
  • teeth that are undergoing pulpotomy or pulpectomy

Exclusion Criteria:

  • systemic disease
  • pulp necrosis
  • permanent teeth
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01486537

Contacts
Contact: Moti Moskovitz, DMD, PhD 00 972 2 6778496 motim@md.huji.ac.il

Locations
Israel
Hadassah Medical Organization, Jerusalem, Israel Recruiting
Jerusalem, Israel, 91120
Contact: Arik Tzukert, DMD    00 972 2 6776095    arik@hadassah.org.il   
Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il   
Principal Investigator: Moti Moskovitz, DMD, PhD         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Moti Moskovitz, Dr. Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: Moti Moskovitz, dr, Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01486537     History of Changes
Other Study ID Numbers: pulpastrop-HMO-CTIL
Study First Received: December 3, 2011
Last Updated: June 12, 2013
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
samples
children
the age group 3-13 years

ClinicalTrials.gov processed this record on November 27, 2014